MINNEAPOLIS--(BUSINESS WIRE)-- DiaMedica Therapeutics Inc. (DMAC), a clinical-stage biopharmaceutical company developing novel treatments for preeclampsia (PE), fetal growth restriction (FGR) and ...

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company developing novel treatments for preeclampsia (PE), fetal growth restriction (FGR) ...

“We believe the meeting minutes provide important regulatory clarity on our non-clinical package as we prepare to submit an IND for the study of DM199 in patients with early-onset preeclampsia,” said ...

The Australian government has announced a gun buyback scheme in the wake of the Bondi Beach attack - its deadliest mass shooting in decades. The scheme is the largest since the Port Arthur massacre in ...